Ana K. Stankovic
Ana K. Stankovic, MD, PhD, MSPH, joined our board of directors in December 2020. Dr. Stankovic brings over 30 years of research and development experience in academic, government, in vitro diagnostic, and device industry settings. Dr. Stankovic currently serves as managing partner of Koliada Consulting LLC, a consulting firm providing strategic and technical advice to pharmaceutical and biotech R&D organizations. From 2003 until January 2018, Dr. Stankovic served in various leadership roles in medical and clinical operations with Becton, Dickinson and Company (BD), most recently as Senior Vice President, World Wide Regional Medical Affairs and Global Health. Prior to her career at BD, Dr. Stankovic served as a medical officer at the Centers for Disease Control and Prevention (CDC), as a clinical pathologist for Quest Diagnostics, Inc., as Consulting Medical Director, Product Investigation Laboratory at Immucor, Inc., and as a medical officer at the American Red Cross. Dr. Stankovic is a board-certified clinical pathologist and a former Chief Resident in the Department of Pathology at the University of Alabama at Birmingham. She received her MD as well as MS and PhD degrees in immunology from the University of Belgrade, and underwent postdoctoral training at, and received her MSPH (health policy and outcomes research) degree from, the University of Alabama at Birmingham.